| Literature DB >> 26559989 |
Gabriela de Azevedo Abreu1, Laura Augusta Barufaldi1, Katia Vergetti Bloch1, Moyses Szklo1.
Abstract
Entities:
Mesh:
Year: 2015 PMID: 26559989 PMCID: PMC4633006 DOI: 10.5935/abc.20150121
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Search strategy used for each database
| Pubmed | (sleep*[Title/Abstract] AND (adoles* OR teen* OR student* OR youth OR young[Title/Abstract]) AND (lipid* OR lipemia* OR cholesterol OR HDL OR LDL OR VLDL OR triglyceride* OR lipoprotein* OR hypercholesterolemia* OR hypercholesteremia* OR dyslipidemia* OR dyslipoproteinemia* OR hyperlipidemia* OR hyperlipemia* OR "high density lipoprotein cholesterol" OR "low density lipoprotein cholesterol"[Title/Abstract])) |
| Lilacs | sleep$ and (adoles$ OR teen$ OR student$ OR youth OR young) and (lipid$ OR lipemia$ OR cholesterol OR HDL OR LDL OR VLDL OR triglyceride$ OR lipoprotein$ OR hypercholesterolemia$ OR hypercholesteremia$ OR dyslipidemia$ OR dyslipoproteinemia$ OR hyperlipidemia$ OR hyperlipemia$ OR "high density lipoprotein cholesterol" OR "low density lipoprotein cholesterol") |
| Adolec | sleep$ [Words] and adoles$ OR teen$ OR student$ OR youth OR young [Words] and lipid$ OR lipemia$ OR cholesterol OR HDL OR LDL OR VLDL OR triglyceride$ OR lipoprotein$ OR hypercholesterolemia$ OR hypercholesteremia$ OR dyslipidemia$ OR dyslipoproteinemia$ OR hyperlipidemia$ OR hyperlipemia$ OR "high density lipoprotein cholesterol" OR "low density lipoprotein cholesterol" [Words] |
| Web of Science | (Topic(sleep*) AND Topic(adoles* OR teen* OR student* OR youth OR young) AND Topic(lipid* OR lipemia* OR cholesterol OR hdl OR ldl OR vldl OR triglyceride* OR lipoprotein* OR hypercholesterolemia* OR hypercholesteremia* OR dyslipidemia* OR dyslipoproteinemia* OR hyperlipidemia* OR hyperlipemia* OR "high density lipoprotein cholesterol" OR "low density lipoprotein cholesterol")) |
| Scopus | (TITLE-ABS-KEY(sleep*) AND TITLE-ABS-KEY(adoles* OR teen* OR student* OR youth OR young) AND TITLE-ABS-KEY(lipid* OR lipemia* OR cholesterol OR HDL OR LDL OR VLDL OR triglyceride* OR lipoprotein* OR hypercholesterolemia* OR hypercholesteremia* OR dyslipidemia* OR dyslipoproteinemia* OR hyperlipidemia* OR hyperlipemia* OR "high density lipoprotein cholesterol" OR "low density lipoprotein cholesterol")) |
Figure 1Flowchart of article selection.
Main characteristics of the selected studies
| Reference/ Country | Study design/ Collection date | Study population | Age | Method for obtaining hours of sleep | Exposure classification (hours of sleep) | Method for lipid profile evaluation | Outcome (alterations of lipids) |
|---|---|---|---|---|---|---|---|
| Gangwisch et
al.[ | Longitudinal | Students, with national representativeness n = 14,257 | 11-21 years boys ≅ 15.8 years old | Questionnaire | Continuous | Questionnaire/
"Has any doctor ever ( | Dichotomous variable |
| Wave I: 1994-95 | |||||||
| Wave II: 1996 | |||||||
| Wave III 2001-02 | 48.7% male | girls ≅ 15.9 years old | Yes/No | ||||
| Kong et
al[ | Cross-sectional/ February 2007 -April 2008 | Students | 12-20 years
old | Questionnaire[ | <6.5h: 20% | Blood collection (TC, TG, HDL, LDL cholesterol) | Hypercholesterolemia |
| TC ≥ 5.2 mmol/L | |||||||
| LDL ≥ 2.6 mmol/L | |||||||
| Actigraphy in sub-sample (n = 138) | 6.5-8h: 40% | HDL <1.0 mmol/L | |||||
| >8h: 20% | Comparison of extreme quintiles | TG ≥ 1.7 mmol/L | |||||
| Narang et
al[ | Cross-sectional/ 2009-2010 | Student n = 3,372 48.9% male | ≅ 14.6 years
old | Questionnaire[ | Continuous | Capillary blood collection without fasting (TC and HDL cholesterol) | TC |
| Borderline: 4.4-5.1 mmol/L: | |||||||
| High: ≥ 5.2 mmol/L | |||||||
| Quartiles | Non-HDL-cholesterol | ||||||
| Borderline: > 3.10 to 3.75 mmol/L | |||||||
| High: > 3.75 mmol/L | |||||||
| Azadbakht et
al[ | Cross-sectional
Data from CASPIAN III | Students n = 5,528 | ≅ 14.69 (2.45) years old boys | Questionnaire | < 5h | Blood collection (TC, TG and LDL) | Abnormal serum
lipids were defined as TC, LDL-C and or TG higher than the level
corresponding to the age and gender-specific 95th percentile[ |
| ≅ 14.7 (2.38) years old girls | 5 to 8h | ||||||
| > 8h | |||||||
| Berentzen et
al[ | Cross-sectional | General population n = 1,481 | Mean age at completion of the questionnaire 11.4 (± 0.3) years | Questionnaire | 7.5-9.5 h | Blood collection (TC and HDL cholesterol) | Continuous variable (mM) |
| 49% male | Mean age at the moment of medical examination 12.7 (± 0.4) years | 10-10.5 h (ref. cat.) | |||||
| 11-12.5 h | |||||||
| Rey-Lopez et
al[ | Cross-sectional/ 2006-2007 | Students n = 699 | ≅ 14.8 years old | Questionnaire | Continuous variable | Blood collection (TG, TC and HDL cholesterol) | Continuous variable (mg/dL) |
| 52% male | |||||||
| Lee et al, 2014/ Republic of Korea[ | Cross-sectional/ 2007-2008 | General population n = 1,187 | ≅ 15 years old | Questionnaire | ≤ 5h | Blood collection (TG and HDL cholesterol) | Continuous variable (mg/dL) |
| 53% male | 6-7h | ||||||
| 8-9h (ref. cat.) | |||||||
| ≥ 10h |
LDL: Low-density lipoprotein; HDL: High-density lipoprotein; TC: Total cholesterol; TG: Triglycerides; BMI: Body mass index.
number of adolescents evaluated; total number of individuals evaluated in the study is 2,053, including children and adolescents;
does not provide average age data or distribution by gender only for the adolescents’ group;
does not provide age group;
non-HDL cholesterol corresponds to total cholesterol minus HDL cholesterol;
CASPIAN III – Childhood and Adolescence Surveillance and Prevention of Adult Non-communicable disease.
Evaluation of the risk of bias of the studies included
| Study | Kong et al[ | Narang et al[ | Azadbakht et al[ | Berentzen et al[ | Rey-López et al[ | Lee et al[ | Gangwisch et al[ |
|---|---|---|---|---|---|---|---|
| Sample representativeness | 0 | 0 | 1 | 0 | 0 | 1 | 0 |
| Definition of presenting condition | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Evaluation of exposure | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Evaluation of outcome | 2 | 1 | 2 | 2 | 2 | 2 | 0 |
| Nonresponse rate | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Representativeness of the exposed cohort | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Demonstration that outcome of interest was not present at start of study | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Comparability of cohorts | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Assessment of outcome | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Was follow-up long enough for outcomes to occur | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Adequacy of follow up of cohorts | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 4/6 | 2/6 | 4/6 | 3/6 | 3/6 | 3/6 | 4/9 |
Cross-sectional studies (maximum 6 points) Sample representativeness: yes (1); no (0); not informed (0) Definition of presenting condition: classification based on two or more lipid markers (1); on only one lipid marker (0) Evaluation of Exposure (hours of sleep): combination of questionnaire with another evaluation method (1); only questionnaire (0) Evaluation of Outcome (lipid profile): venous blood (2); capillary blood (1); self-referred (0) Nonresponse rate: non-respondents described (1); non-described (0)
Cohort studies (maximum 9 points) Evaluation of Exposure (hours of sleep): combination of questionnaire with another evaluation method (1); only questionnaire (0) Evaluation of Outcome (lipid profile): venous blood (2); capillary blood (1); self-reported (0) Representativeness of the exposed cohort (representative of the average): adequately addressed (1); not adequately addressed ⁄ not reported (0) Demonstration that outcome of interest was not present at start of study: adequately addressed (1); not adequately addressed ⁄ not reported (0) Comparability of cohorts on the basis of the design or analysis: adequately addressed (1); not adequately addressed ⁄ not reported (0) Assessment of outcome (independent blind assessment or record linkage): adequately addressed (1); not adequately addressed ⁄ not reported (0) Was follow-up long enough for outcomes to occur: adequately addressed (1); not adequately addressed ⁄ not reported (0) Adequacy of follow up of cohorts (complete follow up or subject slost to follow up unlikely to introduce bias): adequately addressed (1); not adequately addressed ⁄ not reported (0)
Main results of the studies included in the review
| Total | Male | Female | Control variables investigated | ||||
|---|---|---|---|---|---|---|---|
| Gangwisch et al[ | OR (CI 95%) | OR (CI 95%) | OR (CI 95%) | Age/ gender/ race/ ethnic group/ alcohol/ smoke/ physical activity/ inactivity/ stress/ body weight | |||
| Each hour: 0.91 | Each hour: 0.85 | ||||||
| Each hour: 0.87 (0.79-0.96) | (0.79-1.05) | (0.75-0.96) | |||||
| Kong et al[ | β | --- | --- | Age/ sex/ BMI/ waist perimeter/ Tanner stages (2-3 and 4-5) | |||
| (p-value = 0.023) | |||||||
| Azadbakht et al[ | --- | OR (CI 95%) | OR (CI 95%) | Age/ socioeconomic status/ parents' level of education/ family history of chronic disease/ sedentary lifestyle/ BMI | |||
| <5h = 1 | < 5h = 1 | ||||||
| 5–8h = 4.00 (0.54–29.94) | 5–8h = 1.07 (0.31–3.73) | ||||||
| > 8h = 5.63 (0.76–41.56) | >8h = 1.14 (0.33–3.85) | ||||||
| Berentzen et al[ | --- | β (CI 95%) | β (CI 95%) | Age at completion of the questionnaire/ age at medical examination/ height/ maternal level of education/ puberty and screen time | |||
| 7.5–9.5 h = -0.15 | 7.5–9.5 h = -0.01 | ||||||
| (-0.35; 0.04) | (-0.22; 0.21) | ||||||
| 10–10.5 h =1 | 10–10.5 h = 1 | ||||||
| 11–12.5 h = -0.06 | 11–12.5 h = -0.06 | ||||||
| (-0.17; 0.05) | (-0.16; 0.05) | ||||||
| Kong et al[ | β | --- | --- | ||||
| (p-value = 0.042) | |||||||
| Azadbakht et al[ | --- | OR (95%CI) | OR (95%CI) | ||||
| < 5 h = 1 | < 5 h = 1 | ||||||
| 5–8 h = 1.04 (0.30-3.61) | 5–8 h = 1.36 (0.26–5.05) | ||||||
| >8 h = 0.97 (0.28–3.30) | >8 h = 0.76 (0.20–2.89) | ||||||
| Kong et al[ | β | --- | --- | ||||
| (p-value = 0.061) | |||||||
| Berentzen et al[ | --- | β (95% CI) | β(95% CI) | ||||
| 7.5–9.5 h = 0.03 | 7.5–9.5 h = 0.07 | ||||||
| (-0.07; 0.12) 1 | (-0.03; 0.17) | ||||||
| 10–10.5 h = 1 | 10–10.5 h = 1 | ||||||
| 11–12.5 h = 0.02 | 11–12.5 h = <0.01 | ||||||
| (-0.04; 0.07) | (-0.05; 0.05) | ||||||
| Lee et al[ | OR (95%CI) | --- | |||||
| ≤ 5 h = 0.79 (0.40 - 1.53) | |||||||
| 6-7 h = 0.86 (0.50 - 1.49) | --- | ||||||
| 8-9 h = 1 | |||||||
| ≥ 10 h = 1.03 (0.44 - 2.40) | |||||||
| Kong et al[ | β | --- | --- | ||||
| (p = 0.115) | |||||||
| Azadbakht et al[ | --- | OR (95%CI) | OR (95%CI) | ||||
| < 5 h = 1 | < 5 h = 1 | ||||||
| 5–8 h = 1.09 (0.41–2.92) | 5–8 h = 0.53 (0.22–1.30) | ||||||
| > 8 h = 1.16 (0.44–3.09) | > 8 h = 0.53 (0.22–1.30) | ||||||
| Rey-López et al[ | β (95%CI) | --- | --- | Age/ gender/ socioeconomic status/ physical activity | |||
| School days: 0.26 | |||||||
| (-2.57; 3.09) | |||||||
| Weekends: 0.69 | |||||||
| (-1.50; 2.88) | |||||||
| Lee et al[ | OR (95%CI) | --- | --- | Age/ gender/ household income/ caloric intake/ physical activity | |||
| ≤ 5 h= 1.05 (0.55 - 2.00) | |||||||
| 6-7 h= 1.20 (0.79 - 1.83) | |||||||
| 8-9 h= 1 | |||||||
| ≥ 10 h = 2.17 (1.14 - 4.13) | |||||||
| Narang et al[ | OR (95%CI) | --- | --- | Waist perimeter/nutrition/physical activity/sex/ family history of premature cardiovascular disease in first degree relatives/sleep disturbance score | |||
| Each hour | |||||||
| 1.03 (0.93-1.13) | |||||||
| First quartile (reference) x last quartile | |||||||
| 0.92 (0.70-1.22) | |||||||
| Rey-López et al[ | β (95%CI) | --- | --- | ||||
| School days: -0.001 (-0.05; 0.05) | |||||||
| Weekends: 0.009 (-0.03; 0.05) | |||||||
| Berentzen et al[ | --- | β(95% CI) | β(95% CI) | ||||
| 7.5–9.5 h = -0.22 (-0.51; 0.08) | 7.5–9.5 h = -0.18 (-0.44; 0.08) | ||||||
| 10–10.5 h = 1 | 10–10.5 h = 1 | ||||||
| 11–12.5 h = -0.14 (-0.31; 0.02) | 11–12.5 h = -0.04 (-0.17; 0.09) | ||||||
OR: OPdds ratio; CI: Confidence interval; SD: Standard deviation; LDL: Low-density lipoprotein; HDL: Gigh-density lipoprotein; TC: Total cholesterol; TG: Triglycerides; BMI: Body mass index; PR: Prevalence ratio.
β regression coefficient of the multiple regression model to compare groups with the largest and smallest (reference) quintile of the lipid variables in relation to hours of sleep (group with 20% of individual with 20% of individual with longer sleep duration.);
non-HDL cholesterol corresponds to total cholesterol minus HDL cholesterol.